Montillano, Martin Sheen A.
HRN: 24-02-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2024
CEFTRIAXONE 1G (VIAL)
03/01/2024
03/08/2024
IV
1g
Q12
Skin And Soft Tissue Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes